Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Nancy C. Brahm, PharmD, MS, BCPP, CGP

Articles by Nancy C. Brahm, PharmD, MS, BCPP, CGP

(Taking Pills) ©Sheff/Shutterstock.com

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations

ByMegan B. McCorkle, BA,Nicole B. Washington, DO,Nancy C. Brahm, PharmD, MS, BCPP, CGP,Julie Kissack, PharmD, BCPP, FCCP

March 18th 2016

A focus on QTc monitoring in patients receiving psychotropics, especially when multiple medications are prescribed.

Latest Updated Articles

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations
March 18th 2016

Trending on Psychiatric Times

The Real-World Burden of Adult ADHD

How Prevalent Is Simultaneous Alcohol-Cannabis Use?

Why Extended-Release Stimulants Are First-Line for ADHD

When to Switch Schizophrenia Treatment

Rapid Antidepressants and Suicide Risk: What Do We Really Know?